AvePoint (AVPT) grants major equity awards to Executive Chairman

Rhea-AI Filing Summary

AvePoint, Inc. Executive Chairman Xunkai Gong reported new equity awards. He received stock options for 325,947 shares of common stock at an exercise price of $10.52 per share, granted under the 2021 Equity Incentive Plan.

These options vest 25% on March 16, 2027, with the remainder vesting in 12 equal quarterly installments, subject to continued service. He also acquired 190,114 shares of common stock at $0.00 per share, representing restricted stock units and performance-based RSUs tied to 2026–2028 annual recurring revenue growth and FY 2028 GAAP profitability, with actual payouts ranging from 50% to 200% of the granted value.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gong Xunkai

(Last) (First) (Middle)

C/O AVEPOINT, INC.

525 WASHINGTON BOULEVARD, SUITE 1400

(Street)

JERSEY CITY NEW JERSEY 07310

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/16/2026		A		190,114(2)	A	$0	935,203(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)(4)	$10.52	03/16/2026		A		325,947		03/16/2027(5)	03/16/2036	Common Stock	325,947	$10.52	5,575,135	D

Explanation of Responses:

1. This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.

2. Represents performance-based RSUs ("PRSUs") based upon two metrics: Annual recurring revenue compounded annual growth rate for the years 2026-2028 (70% weighted) and FY 2028 GAAP profitability (30% weighted). Actual payouts may represent 50% to 200% of granted value. These PRSUs will fully vest upon certification of the actual payouts by the Issuer's Compensation Committee after the performance period ends.

3. Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024, and March 18, 2025.

4. This security represents options to purchase the Issuer's common stock granted to the reporting person under the Issuer's 2021 Equity Incentive Plan. Each option represents the contingent right to receive, upon exercise of the option, one share of the Issuer's common stock.

5. 25% of the shares underlying these options will vest on March 16, 2027, and the remaining options vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

	/s/ Brian Michael Brown, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did AvePoint (AVPT) report for Xunkai Gong?

AvePoint’s Executive Chairman Xunkai Gong reported equity awards, not open-market trades. He received 325,947 stock options at $10.52 per share and 190,114 shares of common stock as RSU and PRSU grants under the 2021 Equity Incentive Plan.

What are the terms of Xunkai Gong’s new stock options at AvePoint (AVPT)?

Xunkai Gong received options on 325,947 shares of AvePoint common stock with a $10.52 exercise price. Twenty-five percent vest on March 16, 2027, and the remaining options vest in 12 equal quarterly installments, contingent on his continued service with the company.

How many restricted and performance-based shares did AvePoint (AVPT) grant to its Executive Chairman?

AvePoint granted Xunkai Gong 190,114 shares of common stock at $0.00 per share, representing RSUs and performance-based RSUs. The PRSUs pay out between 50% and 200% of the granted value based on 2026–2028 ARR growth and FY 2028 GAAP profitability.

What performance metrics determine AvePoint (AVPT) PRSU payouts for Xunkai Gong?

Performance-based RSUs for Xunkai Gong depend on two measures: annual recurring revenue compounded annual growth rate for 2026–2028, weighted 70%, and FY 2028 GAAP profitability, weighted 30%. After this period, the Compensation Committee certifies actual payouts between 50% and 200%.

How many AvePoint (AVPT) shares does Xunkai Gong hold after these grants?

After the reported grants, Xunkai Gong directly holds 935,203 shares of common stock, including vested and unvested RSUs, and 5,575,135 stock options. These positions reflect equity previously disclosed plus the new awards reported in this Form 4 filing.